2L
RGNX icon

22NW LP’s Regenxbio RGNX Stock Holding History

22NW LP’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.9M Hold
492,759
– – 5.64% 6
2026
Q1 		$4.13M Sell
492,759
-430,920
-47% -$4.53M 2.83% 10
2025
Q4 		$13.3M Hold
923,679
– – 5.6% 5
2025
Q3 		$8.91M Hold
923,679
– – 4.2% 7
2025
Q2 		$7.58M Buy
923,679
+255,000
+38% +$2.13M 4.78% 6
2025
Q1 		$4.78M Buy
+668,679
New +$4.97M 3.21% 10

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

22NW LP's RGNX Position: Q2 2026 in Review

22NW LP held its Regenxbio (RGNX) position steady in Q2 2026 at 492,759 shares worth $5.9M. The position accounts for 5.64% of the portfolio, ranked #6.

22NW LP first reported a position in RGNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.3M in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • 22NW LP held 492,759 shares of Regenxbio worth $5.9M as of Q2 2026.
  • 22NW LP left its Regenxbio share count unchanged in Q2 2026.
  • Regenxbio made up 5.64% of 22NW LP's portfolio in Q2 2026, its #6 holding.
  • 22NW LP first reported a position in Regenxbio in Q1 2025 and has held it in 6 quarters since.
  • 22NW LP's Regenxbio position peaked at $13.3M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on 22NW LP's 13F filing for Q2 2026, filed 14 Aug 2026.